Matinas Biopharma Holdings Inc. (MTNB) Slipped -5.12% or -0.05 To Price $0.91 On Wednesday


Matinas Biopharma Holdings Inc. (MTNB) slipped -5.12% or -0.05 to $0.91. It is near 588785 shares traded, which is 65.84% compare to the average total volume 894273. The market cap of MTNB is $129.49 million. The year to date change is 51.35%. The 52 week price range is from $0.32 to $1.5. Price of MTNB have changed -0.57% during last week. It have changed -13.23% over last month, -26.01% over last 3 months, 17.84% over last 6 months and 74.62% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MTNB is 1.03. It is 13.19% above current price. The 200-day Moving Averages for MTNB is 0.87. It is -4.40% below current price. The 52-week High is 1.5. It is 64.84% from the current price. The 52-week Low is 0.32. It is -64.84% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of MTNB is 6.11 on 2019-05-15. Short % to float is 3.99%. There are some statistics of MTNB. It is has market cap $129.49 million. The share outstanding is 142.99 million. The average volume is 894273. The percent of top 15 Institution holding is 26.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MTNB is -83.87%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MTNB is -49.30%.


Tags:

Share this post